Depressive Disorder, Major Clinical Trial
Official title:
A Randomized Controlled Trial of PCIT-ED for Preschool Depression
Parent Child Interaction Therapy Emotion Development (PCIT-ED) will be conducted with a
sample of preschoolers who exhibit symptoms of depression compared to a wait list (WL)
control after which participants will receive the active treatment. PCIT-ED is an expansion
of PCIT, a well-known, widely used and proven effective treatment for preschool disruptive
disorders. To address early disturbances of mood and affect, a novel ED module was added
based on empirical data in emotion development. The ED module targets parent emotion learning
skills with the goal of training the parent to serve as a more effective emotion teacher and
coach to the child. The goal of the ED module is to enhance the child's capacity for emotion
recognition and regulation or "emotional competence." In order to test the efficacy of
PCIT-ED, to estimate accurate effect sizes and to investigate mediators and moderators of
treatment response participants will complete comprehensive pre-, interval, and
post-assessments.
Preschoolers over 3 will be offered the option of enrolling in an add-on
electroencephalography and magnetic resonance imagery study, to investigate neural changes
associated with PCIT-ED.
Compared to those randomized to the WL, preschoolers who undergo PCIT-ED will show
significantly increased rates of remission, greater reductions in MDD symptoms, and decreases
in impairment; and will show significantly greater increases in emotional competence measured
by the ability to accurately identify emotions in themselves and others and the ability to
effectively regulate intense emotions. Compared to those on the WL, parents who undergo
PCIT-ED will show significantly greater increases in emotion skill learning and reductions in
MDD symptoms and parenting stress.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05915013 -
Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response
|
Phase 1 | |
Completed |
NCT04469322 -
Pharmacogenetic Implementation Trial in Veterans With Treatment Refractory Depression
|
N/A | |
Recruiting |
NCT05415397 -
Treating Immuno-metabolic Depression With Anti-inflammatory Drugs
|
Phase 3 | |
Recruiting |
NCT05988333 -
Psychoeducational Intervention for Families With a Member Affected by Major Depression
|
N/A | |
Completed |
NCT02919501 -
Study of the Efficacy and Safety of Initial Administration of 17 mg Vortioxetine Intravenously With 10 mg/Day Vortioxetine Orally in Patients With Major Depressive Disorder
|
Phase 2 | |
Completed |
NCT00976560 -
Clinical Study to Test a New Drug to Treat Major Depression
|
Phase 2 | |
Recruiting |
NCT05518149 -
A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD)
|
Phase 3 | |
Not yet recruiting |
NCT06303076 -
Tizanidine vs. Zolpidem in Primary Insomnia: A Randomized Trial
|
Phase 4 | |
Not yet recruiting |
NCT05901571 -
Acupuncture and Escitalopram for Treating Major Depression Clinical Study
|
N/A | |
Suspended |
NCT02546024 -
Predictors of Treatment Response in Late-onset Major Depressive Disorder
|
N/A | |
Completed |
NCT02452892 -
Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
|
N/A | |
Completed |
NCT01407575 -
Buprenorphine for Treatment Resistant Depression
|
Phase 3 | |
Completed |
NCT01583400 -
Enhanced Collaborative Depression Treatment in Primary Care: The RESPECT-D-E Trial
|
N/A | |
Completed |
NCT01152996 -
Safety and Tolerability of Vortioxetine (LuAA21004) - Open Label Extension Study
|
Phase 3 | |
Enrolling by invitation |
NCT00762866 -
Psychiatric Genotype/Phenotype Project Repository
|
||
Completed |
NCT00369343 -
Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) Versus Placebo in Peri- and Postmenopausal Women
|
Phase 3 | |
Completed |
NCT00366652 -
Study Evaluating the Effects of DVS SR and Duloxetine on the Pharmacokinetics of Desipramine in Healthy Subjects
|
Phase 3 | |
Completed |
NCT00384033 -
Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) In The Treatment Of Major Depressive Disorder
|
Phase 3 | |
Completed |
NCT00316160 -
Sexual Functioning Study With Antidepressants
|
Phase 4 | |
Completed |
NCT00149643 -
Effectiveness of Fluoxetine in Young People for the Treatment of Major Depression and Marijuana Dependence
|
Phase 2 |